Sleep is defined as a naturally recurring state characterized by altered consciousness, relatively inhibited sensory activity and inhibition of nearly all voluntary muscles. Poor sleep quality results in excessive daytime sleepiness, impaired health status, depressive symptoms and poor quality of life. Upper airway sleep disorders (UASD) are becoming commonly recognized by medical and dental communities. Snoring is a mild form of these disorders. Obstructive Sleep Apnea (OSA) is a severe yet under-diagnosed sleep related breathing disorder. It is characterized by repetitive complete or partial occlusion of the upper airway, resulting in apnea, hypopnea, oxygen desaturation and sleep fragmentation. OSA can lead to a series of systemic, dental and psychological problems if left untreated. Efforts have been made to pin-point the symptoms to effectively evaluate this disorder and to efficiently treat it. This review gives a brief description on the evaluation criteria, associated systemic complications and series of invasive and non invasive treatment options for management and improvement of individuals affected with OSA.
INTRODUCTION
Sleep disorder breathing (SDB) describes a group of disorders characterized by abnormalities of respiratory pattern during sleep. This includes simple snoring, Upper Airway Resistance Syndrome (UARS) and Obstructive Sleep Apnea (OSA). Simple snoring is a common complaint affecting 30 % of the adults and is a sign of airway obstruction. UARS is characterized by resistance to breathing during sleep with day-time sleepiness and excessive fatigue as primary symptoms. OSA is characterized by repetitive upper airway collapse/ narrowing during sleep which results due to inadequate motor tone of tongue/ airway dilator muscles, micrognathia, retrognathia, macroglossia and soft tissue hyperplasia 1 . Studies have shown a strong association of OSA with cardiovascular disease, hypertension, stroke, arrhythmias and insulin resistance. Patients with OSA have 30 % more risk of heart attack than those unaffected 3 . Repetitive apnea exposes the cardiovascular system to a cascade of intermittent hypoxia, exaggerated negative intra-thoracic pressure, which in turn surges the sympathetic nervous system activity (SNA) and blood pressure and frequent awakening, all of which may have adverse cardiovascular consequences 4 .
Epidemiology
Prevalence rate of OSA from the Wisconsin sleep cohort study in patients aged 30-60 years was 9-24 % for males and 4-9 % for women 3 . Prevalence of OSA is similar in Caucasians and Asians, indicating that OSA is not only common in developing but also in developed countries. However, the disease prevalence is higher in the subgroups with overweight or obese subjects and elderly people. Inter-ethnic studies suggest that AfricanAmerican ethnicity may be at significant risk for developing OSA. The increased prevalence of OSA among American, Indian and Hispanic adults, and increased severity among Pacific Islanders and Maoris, were mainly explained by the increased obesity indices 2 . The primary risk factor for OSA includes the male gender, those over the age of 40, overweight individuals, and BMI in particular is the strongest risk factor. Twenty six percent of patients with BMI greater than 30 % and 33 % of those with BMI greater than 40 % are at a moderate risk. Neck circumference of 15.7 (40 cm) may have a greater sensitivity and specificity than BMI in predicting OSA, regardless of the person's sex. Incidence of OSA among male and female are 3:1 prior to menopause. There is at least three fold increases in the risk of OSA among post menopausal women compared to premenopausal women.
Pathophysiology
Patients with OSA generally have narrow pharynx which is contributed by two major factors-(i) craniofacial structural abnormalities and (ii) larger soft tissue mass or abnormal tissue deposits which can also increase extraluminal tissue pressure and lowers the threshold for airway collapse. Additional anatomical factors include the sleeping posture which strongly influences the collapsibility of airway by the gravitational force which causes retropulsion of tongue and soft palate while lying supine, thus generating increased positive pressure and narrowing the airway 3 . OSA contributes to the development or progression of Heart Failure (HF), although a possibility does exist that HF might contribute to causation of OSA. This could be due to the flow of accumulated fluid in the leg while upright during day and flows into the neck when recumbent during sleep there by, causing distention of the neck vein and/ or oedema of the peri-pharyngeal soft tissue which increases the peripharyngeal tissue pressure, predisposing to pharyngeal obstruction 4 .
Evaluation
Sleep apnea is usually recognised as a problem by family members who witness the apneic episodes or by a primary care doctor by the individual's risk factors and symptoms. Clinical symptoms can include excessive daytime sleepiness (EDS) that usually begins during quiet activities, daytime fatigue, feeling tired despite a full night's sleep, morning headaches, personality and mood changes, dry or sore throat, gastroesophageal reflux and sexual dysfunction. Diagnosis of OSA is based on the evaluation of clinical symptoms and risk factors with screening questionnaires, as well as a physical examination. Epsworth Sleepiness Scale (ESS) is a questionnaire used to help determine how frequently the patient is likely to doze off in 8 frequently encountered situations. ESS is a subjective self assessment measure and may be inaccurate for a number of reasons. Therefore, if a patient has multiple risk factors for sleep apnea, the individual should be sent for further evaluations if there is a suspicion of sleep apnea despite a low ESS. Berlin questionnaire is another effective screening tool which addresses snoring behaviour, EDS/ fatigue and history of obesity or hypertension with sensitivity regards to high risk patient being 86 % 4 . STOP BANG questionnaire term refers to mnemonic that represents 8 most common risk factors: Snoring, Tiredness, Observed apneas, elevated blood Pressure, BMI, Age, Neck circumference and Gender. The patient receives a point for each positive risk factor. A score of 3 or more represents a higher likelihood of OSA 5 . Physical examination includes obesity, enlarged neck circumference, and/ or structural cranio-facial bony abnormalities, hypothyroidism and acromegaly. Mallampati score is used routinely by sleep physicians to evaluate the risk of OSA. The classification provides a score between 1 and 4 based on the anatomic appearance of the airway seen when an individual opens his mouth 6 . Polysomnography (PSG) is a formal sleep evaluation test to quantify the amount of time spent in various stages of sleep during the night and to clinically document the relevant events such as cardiopulmonary abnormalities and/ or changes in sleep stages. PSG includes a limited multi-channel recording of an individual's electroencephalography (EEG) to assess the sleep architecture, sleep stages and arousals. In addition, surface electromyography of the chin and all the four limbs along with electro-oculogram, airflow, pulse oximetry, respiratory effort, electrocardiographic (ECG) tracing, body position and snoring are accumulated. Portable polysomnographic device gives an advantage to perform the study overnight at individual's home and is cost effective. The main limitation lies in the fact that it does not have an EEG component, therefore its might show greater inability to assess the individual's sleep architecture and arousals patterns 7, 8 .
Diagnosis
Apnea is defined as a more than 90 % reduction in tidal volume lasting for 10 seconds. Hypopnea is a reduction in tidal volume of 50 % to 90 %, lasting for 10 seconds accompanied by a 3 % decrease in oxyhemoglobin saturation (SaO 2 ) or terminated by arousal from sleep. OSA is generally defined as the presence of more than 5 episodes of apnea or hypopnea per hour of sleep (i.e. Apnea Hypopnea Index [AHI]) and when accompanied by either hyper somnolence or at least 2 episodes of choking or gasping during sleep, recurrent awakening, un refreshing sleep, daytime fatigue, impaired concentration or memory, is called as an OSA syndrome 4 . AHI is an index used to assess the severity of sleep apnea based on the total number of apnea and hypopnea occurring per hour of sleep. Severity of the disease can be stratified using AHI. An AHI score of 5-15 is classified as mild, 15-30 is considered moderate and greater than 30 is considered severe 9 . OSA is usually confirmed by overnight polysomnography or portable cardio respiratory monitor devices used to study sleep architecture, cardiac rhythm, SaO 2, airflow and thoraco-abdominal movements.
Systemic Complications
OSA has been widely recognized as an important risk factor for hypertension, cardiovascular disease (CVD), stroke and death. The underlying pathogenesis is particularly intermittent hypoxia which triggers the sympathetic nerve activity, systemic inflammation and oxidative stress, causing endothelial cell dysfunction, systemic inflammation, metabolic dysregulation and coagulopathy. The absolute key factor however remains unknown 9 .
Hypertension
Cross sectional analyses suggests OSA as an identifiable and independent cause of hypertension and frequent blood pressure monitoring is recommended for such individuals. Oxygen desaturation during apnea/hypopnea increases sympathetic activity secondary to micro arousals at night, nocturnal fluctuations in catecholamines are some of the prominent factors in the causation of hypertension [10] [11] [12] . Dependent and independent vasodilatation due to endothelial dysfunction may also result in raised peripheral vascular resistance and consequently, hypertension 7 .
Coronary artery disease
Circulatory physiology is greatly affected by change in sleep pattern, OSA related hypoxia, hypercapnia, blood pressure surges due to sympathetic over activation and the acute imbalance of vasoactive hormones. These changes not only provoke acute coronary syndromes but also, their persistence ultimately leads to chronic consequences such as heart failure 13 .
Cerebrovascular diseases
Sleep disordered breathing is highly prevalent amongst stroke patients and is regarded as a poor prognostic marker due to the associated sub-total/total paralysis of facial and pharyngeal muscles 14, 15 . Nevertheless, further data is needed to determine whether OSA is related to cerebrovascular morbidity independent of other vascular risk factors.
Heart failure
Patients with heart failure per se have a high prevalence of OSA. This might be attributed to oedema of neck soft tissues which makes the pharyngeal tissue prone to collapse, thereby leading to further tightening of the airway 16, 17 .
Cardiac arrhythmias
Abnormal cardiac pattern of sudden deaths amongst OSA could possibly be explained due to higher incidences of life threatening ventricular arrhythmias amongst patients with sleep disorders 18 . OSA not only increases the prevalence of atrial fibrillation (AF) but also predicts predischarge AF after surgery and recurrent post ablation 16, [19] [20] [21] .
Chronic kidney disease (CKD)
High prevalence of OSA and its influence on cardiovascular events have been reported among individuals with end-stage renal disease 22, 23 . Prevalence and severity of OSA among non dialysis CKD patients is considerably higher than those in the general population, in which 1 of 5 adults suffered mild OSA and significant increase in the risk of OSA was associated in individuals with decreased GFR 24 . Narrowing of pharyngeal cross section by 12 % less than that in the normal individuals is one of the factors associated with decreased GFR 6 .
Management

Continues positive air pressure (CPAP)
The most common and effective treatment for OSA is continuous positive airway pressure (CPAP), which decreases no of apnea and hypopnea episodes and reduces the amount of oxygen desaturation over night 26 . It consists of a mask containing a tube which connects to the oxygen device and fits over the nose, supplying a steady stream of air and pressure to prevent the tissues from collapsing during sleep 27 . Randomized clinical trials have demonstrated improvement in many health outcomes like subjective sleepiness, quality of life (QOL), blood pressure and long term treatment which may reduce the incidence of cardiovascular events, at least in patients with severe OSA [28] [29] [30] [31] . Recent meta-analysis conclusively states that CPAP reduces subjective and objective daytime sleepiness when compared with pill placebo or placebo CPAP 29, 32 . Health outcome in patients with moderate to severe OSA were similar after treatment with CPAP and Mandible Advancement Devices (MAD). However, it is recommended that MAD treatment should be considered in patients with mild to moderate OSA or in individuals who have failed or refuse CPAP treatment 33 .
Dental Devices
American Academy of Sleep Medicine recommends dental device for patients with mild to moderate obstructive sleep apnea who are not appropriate candidates for CPAP or who have not been helped by it. Oral devices are of two basic configurations, the tongue retaining device (TRD) and the MAD which generally works by directly or indirectly preventing the tongue from approaching the posterior wall of the pharynx and hence maintaining the airway space 27, 34 . Although the two appliances have similar treatment effects of reducing AHI; the higher response rate, over all acceptance and compliance of MAD suggests that it is a superior treatment for OSA in the clinical set up 35, 36 . Although, dental devices significantly reduce apnea in patients sleeping on their back or stomach, it does not work well in individuals lying on their side 27 .
Surgical Procedures
The aim of OSA surgery is to eliminate the airway collapse and to reduce airway resistance during sleep without causing impairment to the normal function of the upper airway and associated structures. General indications for surgery include moderate to severe OSA, excessive daytime sleepiness (even when the AHI is ≤ 20/h), OSA with co-morbid conditions (e.g. arrhythmias, hypertension), with anatomic airway abnormalities and failure of medical OSA management 37 . Relative contraindications to surgery include morbid obesity (except for bariatric surgery and tracheotomy), severe or unstable cardiopulmonary disease, active alcohol/ illicit drug abuse, older age, unstable psychological problems, or unrealistic expectations from surgical therapy 38 .
Various surgical procedures are now available to increase the posterior airspace and to successfully treat OSA in CPAP intolerant patients. However, treatment outcome is considered successful when an AHI less than 20 and a reduction in AHI of 50 % or more is attained after surgery 47 .
Tracheotomy
Kuhlo et al in 1969 effectively treated OSA by means of a tracheotomy by by-passing the upper airway 42 .
Tracheotomy is effective at preventing arrhythmias, reducing pulmonary artery pressure and improving hypertension and diabetes in patients with OSA along with reported resolution of nocturnal symptoms and daytime sleepiness [41] [42] [43] . Unfortunately, tracheotomy has several problems including patient dissatisfaction (e.g. psychosocial aspects), post-operative complications (e.g. wound infection, tissue necrosis, bleeding), recurrent bronchitis, granulation tissue and stomal stenosis [44] [45] [46] [47] . Permanent tracheotomy is used in highly selected cases with severe OSA who are intolerant of CPAP unlike temporary tracheotomy which is used before other OSA procedures (e.g. uvulopalatopharyngoplasty, bariatric surgery) to protect the airway, particularly in morbidly obese subjects 48 .
Uvulopalatopharynoplasty (UPPP)
In 1980 Fujita and Conway et al reported UPPP as a technique to enlarge the oropharyngeal airway lumen by excising redundant tissues from the soft palate, tonsillar pillars and uvula 49, 50 . It reduces the risk of nasopharyngeal incompetence and is associated with less postoperative pain. It is however contraindicated in patients with excessively long or bulky soft palate 51, 52 . UPPP lowers the positive airway pressure requirements, thus improving CPAP compliance in selected patients 53 . Early postoperative complications include wound dehiscence, haemorrhage, infection and transient velopharyngeal incompetence (nasal regurgitation and hypernasal speech) 54 . Late postoperative complications include pharyngeal discomfort (dryness, tightness), postnasal secretions, dysphasia, inability to initiate swallowing, odynophagia, nasopharyngeal stenosis, taste and speech disturbances, tongue numbness and rarely permanent velopharyngeal incompetence 55, 56 .
Laser assisted palatoplasty (LAUP)
Laser assisted palatoplasty is a procedure similar to uvulopalatopharyngoplasty, but it uses a CO 2 laser to shape the soft palate and is an effective surgical technique for snoring. However, it has limited OSA efficacy 57 . Two randomized trials of LAUP found no significant change in the AHI and daytime sleepiness (measured by the Epworth sleepiness scale) between surgery and control groups 58 . LAUP is not approved by the American Academy of Sleep Medicine to treat OSA 59 . In addition, common complication includes early postoperative pharyngeal oedema, with up to 59 % complaining of persistent side effects after LAUP 60, 61 .
Tonsillectomy
Tonsillectomy is one of the most common surgical procedures in and is considered as a first-line therapy for children's with OSA 62, 63 . Complete resection of the tonsils with adenoidectomy is preferred over partial intra capsular tonsillectomy (tonsillotomy) as it reduces postoperative morbidity (pain), but postoperative objective measures of efficacy (AHI reduction) are lacking [65] [66] [67] . Tonsillectomy improves quality of life parameters in children with OSA, with improvements in the behaviour scores and sleep disturbances [68] [69] [70] [71] .
Radiofrequency Ablation (RFA)
RFA can be considered as a treatment in patients with mild to moderate obstructive sleep apnea who cannot tolerate or who are unwilling to adhere to positive airway pressure therapy, or in whom oral appliance have been considered and found ineffective or undesirable 72 . Somnoplasty involves directed radiofrequency energy to ablate and reduce soft tissues of the palate thereby, decreases snoring by scar-induced stabilization of the soft palate [73] [74] [75] . A randomized placebo-controlled trial in patients with mild OSA found no statistically significant improvement in the AHI or symptoms after somnoplasty 76 .
Pillar Palatal Implants
This procedure involves inserting matchstick size rigid polyester implants via a hollow needle delivery tool into the soft palate which improves snoring by stiffening the soft palate, but their effect on OSA is less clear and the long-term benefits on OSA are unknown [77] [78] [79] [80] [81] .
Biatric surgery
Surgically induced weight loss was first performed in 1967 and is safe, results in marked and sustained weight loss, and is associated with improved mortality compared to conventional weight-loss strategies [82] [83] [84] . Surgically induced weight loss improves the AHI. However, more than 50 % of bariatric recipients with preoperative OSA have a residual disease despite weight loss 85 . CONCLUSION OSA is a common complication which affects the population worldwide. The prevalence and consequence of OSA is likely to increase in years to come. However, its diagnosis and treatment is still not a common approach especially in developing countries. Medical communities face many hurdles regarding the development of adequate early screening and appropriate treatment. It is well known fact that effects of OSA is far reaching, and early detection/treatment will be beneficial to individual patients, as well as cost effective public health measure to reduce morbidity and mortality. Physicians of all specialities should screen for the presence of sleep disturbance and consider referral to a sleep specialist when indicated.
